51成人动漫

Rheumatology >

General Rheumatology

News, opinions and meeting coverage in rheumatology.

Pulmonary Hypertension: Not Just for Cardiologists

PH is common in many rheumatologic conditions

Has Pendulum Swung Too Far on Bisphosphonates?

Saag: Physicians and patients may be overreacting to risks with long-term treatment

Novel Tx Eases Osteoarthritic Knee Pain

Geniculate artery embolization promising for knee pain, stiffness

Can Biologics Treat Damaged Cartilage?

Overall response rate was 63%, but complete responses only in 19%

One Gout Medication Comes Out on Top for CV Risk

Allopurinol the loser in retrospective comparison of two drugs

Q&A: Avindra Nath, MD

Leading NIH study of post-infection chronic fatigue syndrome

Pearls From: David Rubin, MD

Expert discusses how to treat C. diff in IBD patients

Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trial

Risankizumab broadly effective against joint and skin symptoms

PsA Structural Damage Inhibited with Secukinumab

Loading dose appears to improve outcomes, researchers say

Novel Drug Promising for IgG4-Related Disease

8 of 15 patients achieved remission in phase II study

Prospects Good for Ustekinumab Gaining SLE Indication

Positive phase II data reported in ACR late-breaker

ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologics

Selections from late-breaker poster presentations at rheumatology meeting

Mixed Results in Studies of Biosimilar-Originator Switching

Is there a nocebo effect in changing between drugs supposed to be equal?

Tool Available to Help Rheumatologists Cope with MIPS

Eases reporting needed to avoid penalties, earn incentive payments under MACRA

Lipid Changes with Sirukumab Called 'Anti-Atherogenic'

Looking for silver-lining in cloudy trial data

Bruton's Tyrosine Kinase Marches on as Rheumatology Target

Industry remains interested despite lackluster phase II results with Celgene drug

In RA Patients, 2-Week Methotrexate Holiday Boosts Flu Vax Efficacy

Pragmatic trial shows 15%-20% bump in antibody titers

ACR 2017: Biosimilar Debate, Inflammation in OA, and More

Special lecture will look back at TNF as rheumatology drug target

ESC: No BP Spike Seen with Celecoxib Use

But ibuprofen boosts systolic pressure

Helping Kids with Chronic Diseases Move to Adult Care

Program at Wisconsin hospital develops self-management skills

Does Fibromyalgia Mask Spondyloarthritis?

A new study sheds some light on this relationship

Moderate Alcohol Intake OK for RA Patients on Methotrexate

Patients on higher doses of meds may still need to abstain

Mortality Still High in Vasculitis

Risk 2.7-fold higher than in the general population, meta-analysis showed

Cimzia Passes Muster in Two Psoriasis Trials

Met primary efficacy goals versus placebo; third trial still to come

A Rocky Start for Biosimilar Inflectra?

Infliximab biosimilar approved, but obstacles remain

Knee OA No Excuse to Skip Out on Physical Activity

Patients met thresholds for sit-to-stand, gait speed, and walking speed

Lowering Urate Helps Renal Function

Most improvement seen in stage 3 chronic kidney disease

ACR: Actemra Found Steroid-Sparing in GCA

The era of unending steroid treatment is over

AHA: Study Finds Celebrex Safe for Heart

But naproxen not as heart safe as believed

MedPAC Looks at Ways to Adjust Misvalued Services

Commission debates grouping CPT codes into families

301 People Charged With $900 Million in False Medicare Billings

Largest sweep since government fraud team began in 2007

How to Avoid Misdiagnosis

How a patient makes you feel may affect your diagnostic acumen

Blindness Still a Worry in GCA

Patients with prevalent vascular disease have particularly high risk

Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

10 Questions: Ilona J. Frieden, MD

'The structure of the system itself is the biggest barrier'

Here's Why You Can't Compare Healthcare to the Airline Industry

There are big differences between the two, says Suneel Dhand, MD

RheumNow: Drugs That May Induce Raynaud's

Incidence of side effect is probably underestimated

When "Unremarkable" Is Not Clear Enough

Radiology reports need to be held to higher standards, argues Saurabh Jha, MD

Methotrexate Safe With Chronic Hepatitis B Infection

Study suggests contraindication should be reconsidered

Anti-IL17A Tx Clears Most Cases of Psoriasis

Durable long-term responses with ixekizumab, secukinumab

鈥�

14